Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization

被引:30
作者
Cho, JH [1 ]
Lee, SW [1 ]
Sung, YC [1 ]
机构
[1] Pohang Univ Sci & Technol, Sch Environm Engn, Ctr Biofunct Mol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea
关键词
hepatitis C virus; nonstructural protein; DNA immunization; bicistronic plasmid;
D O I
10.1016/S0264-410X(98)00333-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis C virus (HCV) nonstructural (NS) proteins appeared to be important targets for HCV vaccine development, since NS-specific T-helper-cell responses are associated with clearance from acute HCV infection. In this report, we have constructed a plasmid, pTV-NS345, that encodes the HCV NS3, NS4 and NS5 proteins (NS345) and a bicistronic plasmid, PIV-NS345/GMCSF, in which the HCV NS345 polyprotein and GMCSF are translated independently. Intramuscular inoculation with pTV-NS345 plasmid DNA into the Buffalo rats generated both antibody and T-cell proliferative responses to each NS protein. The expression of GMCSF, together with HCV NS345 proteins, appeared to significantly increase T-cell proliferative responses. In particular, the inoculation of a bicistronic plasmid generated higher T-cell proliferative responses to each NS protein than did the coinjection of two separate plasmids, pTV-NS345 and pTV-GMCSF. These results demonstrate that the codelivery of GMCSF augmented HCV NS345-specific cellular immunity and that the intensity of the immunity was differed depending on how GMCSF gene is codelivered. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1136 / 1144
页数:9
相关论文
共 64 条
[1]   DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[2]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[3]   ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE [J].
BATTEGAY, M ;
MOSKOPHIDIS, D ;
RAHEMTULLA, A ;
HENGARTNER, H ;
MAK, TW ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4700-4704
[4]   PATIENTS WITH CHRONIC HEPATITIS-C HAVE CIRCULATING CYTOTOXIC T-CELLS WHICH RECOGNIZE HEPATITIS-C VIRUS-ENCODED PEPTIDES BINDING TO HLA-A2.1 MOLECULES [J].
BATTEGAY, M ;
FIKES, J ;
DIBISCEGLIE, AM ;
WENTWORTH, PA ;
SETTE, A ;
CELIS, E ;
CHING, WM ;
GRAKOUL, A ;
RICE, CM ;
KUROKOHCHI, K ;
BERZOFSKY, JA ;
HOOFNAGLE, JH ;
FEINSTONE, SM ;
AKATSUKA, T .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2462-2470
[5]   LYMPHOCYTE-T RESPONSE TO HEPATITIS-C VIRUS IN DIFFERENT CLINICAL COURSES OF INFECTION [J].
BOTARELLI, P ;
BRUNETTO, MR ;
MINUTELLO, MA ;
CALVO, P ;
UNUTMAZ, D ;
WEINER, AJ ;
CHOO, QL ;
SHUSTER, JR ;
KUO, G ;
BONINO, F ;
HOUGHTON, M ;
ABRIGNANI, S .
GASTROENTEROLOGY, 1993, 104 (02) :580-587
[6]  
Bright RK, 1996, CANCER RES, V56, P1126
[7]   Nucleic acid vaccination against virally induced tumors [J].
Bright, RK ;
Shearer, MH ;
Kennedy, RC .
DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 :241-251
[8]  
CERINO A, 1991, J IMMUNOL, V147, P2692
[9]   CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF [J].
CERNY, A ;
MCHUTCHISON, JG ;
PASQUINELLI, C ;
BROWN, ME ;
BROTHERS, MA ;
GRABSCHEID, B ;
FOWLER, P ;
HOUGHTON, M ;
CHISARI, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :521-530
[10]  
CHIBA Y, 1976, J IMMUNOL, V116, P12